---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-025869"
form_type: "8-K"
ticker: "XTNT"
cik: "0001453593"
company_name: "Xtant Medical Holdings, Inc."
filed_at: "2023-07-28T23:59:59+00:00"
generated_at: "2026-06-12T22:56:32.102124+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Xtant Medical wins auction for Surgalign's biologics and spinal fixation assets

## Summary
- Won auction for Surgalign's domestic and international biologics and spinal fixation assets via initial bid from June 18 APA.
- Closing expected after Bankruptcy Court sale hearing on Aug 8, 2023, but no later than Sep 1, 2023.
- CEO Sean Browne expects assets to contribute to growth, complementing earlier Coflex acquisition.

## SEC filing metadata
- accession: 0001493152-23-025869
- form_type: 8-K
- ticker: XTNT
- cik: 0001453593
- company_name: Xtant Medical Holdings, Inc.
- filed_at: 2023-07-28T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453593/000149315223025869/0001493152-23-025869-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453593/000149315223025869/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-025869
- JSON: https://secwatch.observer/filing/0001493152-23-025869.json
- Plain text: https://secwatch.observer/filing/0001493152-23-025869.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.